SUPN
Supernus Pharmaceuticals, Inc. · Healthcare · Drug Manufacturers - Specialty & Generic
Momentum inputs (comparable managers): holder breadth 0.0% · share flow +6.4% · net new positions 0.0% — formula
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 103 | +2 | 42.42M | $1.97B | +5 | −3 |
| Q1 2026 | 104 | -3 | 41.20M | $2.13B | +5 | −9 |
| Q4 2025 | 107 | 0 | 43.16M | $2.15B | +1 | — |
| Q3 2025 | 18 | -1 | 27.64M | $1.32B | — | −2 |
| Q2 2025 | 17 | 0 | 22.78M | $717.88M | — | — |
| Q1 2025 | 14 | 0 | 6.75M | $221.22M | — | — |
| Q4 2024 | 14 | 0 | 6.49M | $234.56M | +1 | −1 |
| Q3 2024 | 13 | 0 | 4.54M | $141.67M | +1 | −1 |
| Q2 2024 | 13 | — | 4.27M | $114.18M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Renaissance Technologies ✦ | 1.73M | +2.6% | $53.90M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passive) | 1.48M | +5.3% | $46.22M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 3 | D. E. Shaw & Co. ✦ | 408.79K | +40.6% | $12.75M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 4 | Millennium Management ✦ | 252.74K | +56.7% | $7.88M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | Norges Bank ✦ (passive) | 162.33K | -22.3% | $5.06M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 6 | Citadel Advisors ✦ | 104.25K | -27.1% | $3.25M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 7 | Arrowstreet Capital ✦ | 97.52K | New | $3.04M | 0.0% | New | 1 | SEC ↗ |
| 8 | Two Sigma Investments ✦ | 84.57K | +74.2% | $2.64M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 9 | AQR Capital Management ✦ | 59.81K | +328.6% | $1.86M | 0.0% | ▲ Add | 2 | SEC ↗ ×3 |
| 10 | Marshall Wace ✦ | 51.14K | -30.4% | $1.59M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 11 | T. Rowe Price ✦ | 47.40K | -0.3% | $1.48M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 12 | Gotham Asset Management ✦ | 37.79K | +242.0% | $1.18M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 13 | Wellington Management ✦ | 26.33K | -35.3% | $820,844 | 0.0% | ▼ Trim | 2 | SEC ↗ ×4 |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| Arrowstreet Capital | $3.04M | 0.0% |
Exited
| Point72 Asset Management | $3.65M | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 323 holders, 57.94M shares, $2.88B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.